Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07467512Not ApplicableNot Yet Recruiting

Exercise for an Aging Liver (EXALIVER)

Role: collaborator

NCT06214624Not ApplicableCompleted

Exercise and Brain in Coronary Heart Disease

Role: collaborator

NCT06584656Not ApplicableCompleted

Understanding Cerebral Blood Flow Dynamics for Alzheimer's Disease Prevention Through Exercise

Role: collaborator

NCT05186090Not ApplicableCompleted

Active Gains in Brain Using Exercise During Aging

Role: collaborator

All 4 trials loaded